Zobrazeno 1 - 10
of 116
pro vyhledávání: '"M E, Evangelopoulos"'
Autor:
D. Tzanetakos, A. G. Vakrakou, J. S. Tzartos, G. Velonakis, M. E. Evangelopoulos, M. Anagnostouli, G. Koutsis, E. Dardiotis, E. Karavasilis, P. Toulas, L. Stefanis, C. Kilidireas
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Baló’s Concentric Sclerosis (BCS) is a rare heterogeneous demyelinating disease with a variety of phenotypes on Magnetic Resonance Imaging (MRI). Existing literature lacks data especially on the therapeutic approach of the dise
Externí odkaz:
https://doaj.org/article/1bfd47c15c804e0b96f780121bccf761
Autor:
A. G. Vakrakou, D. Tzanetakos, S. Valsami, E. Grigoriou, K. Psarra, J. Tzartos, M. Anagnostouli, E. Andreadou, M. E. Evangelopoulos, G. Koutsis, C. Chrysovitsanou, E. Gialafos, A. Dimitrakopoulos, L. Stefanis, C. Kilidireas
Publikováno v:
BMC Neurology, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background Alemtuzumab has been demonstrated to reduce the risks of relapse and accumulation of sustained disability in Multiple Sclerosis (MS) patients compared to β-interferon. It acts against CD52, leading primarily to lymphopenia. Recen
Externí odkaz:
https://doaj.org/article/8e8fe25d2f634e06b5bd74dfa84b4580
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
E. Andreadou, E. Kemanetzoglou, Ch. Brokalaki, M. E. Evangelopoulos, C. Kilidireas, A. Rombos, E. Stamboulis
Publikováno v:
Case Reports in Neurological Medicine, Vol 2013 (2013)
Tumor necrosis factor antagonists (anti-TNFa) are an established therapeutic option for several autoimmune and inflammatory bowel diseases. Despite their clinical effectiveness, neurological adverse events have been reported and literature data sugge
Externí odkaz:
https://doaj.org/article/19658e21bcf54fe58a3bf046e5bcea5f
Autor:
George Koutsis, Panagiotis Toulas, M. E. Evangelopoulos, Efthymios Dardiotis, Leonidas Stefanis, George Velonakis, Dimitrios Tzanetakos, John Tzartos, Maria Anagnostouli, C. Kilidireas, Aigli G Vakrakou, Efstratios Karavasilis
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Neurology
BMC Neurology
Background Baló’s Concentric Sclerosis (BCS) is a rare heterogeneous demyelinating disease with a variety of phenotypes on Magnetic Resonance Imaging (MRI). Existing literature lacks data especially on the therapeutic approach of the disease which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acf0530bbd93aacfb78821057cc4db89
https://doi.org/10.1186/s12883-020-01971-2
https://doi.org/10.1186/s12883-020-01971-2
Autor:
M. E. Evangelopoulos, Leonidas Stefanis, Georgios Koutsis, Panagiotis Toulas, Elisabeth Andreadou, Elias Gialafos, Constantinos Kilidireas, A. Dimitrakopoulos, Marianthi Breza, Maria Anagnostouli, Aigli G Vakrakou, Theodore Argyrakos, Dimitrios Tzanetakos, John Tzartos, Georgios Velonakis
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Frontiers in Neurology
Frontiers in Neurology
Atypical forms of demyelinating diseases with tumor-like lesions and aggressive course represent a diagnostic and therapeutic challenge for neurologists. Herein, we describe a 50-year-old woman presenting with subacute onset of left hemiparesis, memo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708f1a12aa3b6d48dfdc94f5b9a5fa94
https://www.frontiersin.org/article/10.3389/fneur.2020.00536/full
https://www.frontiersin.org/article/10.3389/fneur.2020.00536/full
Autor:
Tzanetakos, D., A. G. Vakrakou, J. S. Tzartos, G. Velonakis, M. E. Evangelopoulos, M. Anagnostouli, G. Koutsis, E. Dardiotis, E. Karavasilis, P. Toulas, L. Stefanis, C. Kilidireas
Additional file 1: Supplementary Figure 1. MRI of Case 2 showing BCS-type lesion before and after treatment with cyclophosphamide. Supplementary Figure 2. MRI of Case 3 showing BCS-type lesion before and after mitoxantrone treatment. Supplementary Fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20ea7fa874aac3a5b8c83c806fa1a4e0
Autor:
Maria Anagnostouli, Serena Valsami, Leonidas Stefanis, Elissavet Andreadou, C. Kilidireas, Dimitrios Tzanetakos, John Tzartos, A. Dimitrakopoulos, E. Grigoriou, Aigli G Vakrakou, K. Psarra, Chrysa Chrysovitsanou, Elias Gialafos, M. E. Evangelopoulos, Georgios Koutsis
Publikováno v:
BMC Neurology, Vol 18, Iss 1, Pp 1-6 (2018)
BMC Neurology
BMC Neurology
Background Alemtuzumab has been demonstrated to reduce the risks of relapse and accumulation of sustained disability in Multiple Sclerosis (MS) patients compared to β-interferon. It acts against CD52, leading primarily to lymphopenia. Recent data ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::763ef4b2497848047f68dad7ef9c881a
http://link.springer.com/article/10.1186/s12883-018-1183-4
http://link.springer.com/article/10.1186/s12883-018-1183-4
Publikováno v:
Case Reports in Medicine, Vol 2011 (2011)
A 45-year-old female suffering from severe thoracic pain was admitted to the emergency department of our hospital. Thorough clinical examination revealed paresis of the left lower limb and sensory deficit at the level of the Th4 vertebra. MRI of the
Externí odkaz:
https://doaj.org/article/807b79ee4bbc4fb680f6f240027704b9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.